1. Home
  2. ARQT vs NTCT Comparison

ARQT vs NTCT Comparison

Compare ARQT & NTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQT
  • NTCT
  • Stock Information
  • Founded
  • ARQT 2016
  • NTCT 1984
  • Country
  • ARQT United States
  • NTCT United States
  • Employees
  • ARQT N/A
  • NTCT N/A
  • Industry
  • ARQT Biotechnology: Pharmaceutical Preparations
  • NTCT EDP Services
  • Sector
  • ARQT Health Care
  • NTCT Technology
  • Exchange
  • ARQT Nasdaq
  • NTCT Nasdaq
  • Market Cap
  • ARQT 1.7B
  • NTCT 1.7B
  • IPO Year
  • ARQT 2020
  • NTCT 1999
  • Fundamental
  • Price
  • ARQT $13.89
  • NTCT $24.72
  • Analyst Decision
  • ARQT Strong Buy
  • NTCT Hold
  • Analyst Count
  • ARQT 6
  • NTCT 1
  • Target Price
  • ARQT $18.80
  • NTCT $25.00
  • AVG Volume (30 Days)
  • ARQT 1.9M
  • NTCT 495.5K
  • Earning Date
  • ARQT 08-13-2025
  • NTCT 07-24-2025
  • Dividend Yield
  • ARQT N/A
  • NTCT N/A
  • EPS Growth
  • ARQT N/A
  • NTCT N/A
  • EPS
  • ARQT N/A
  • NTCT N/A
  • Revenue
  • ARQT $212,819,000.00
  • NTCT $822,679,000.00
  • Revenue This Year
  • ARQT $61.15
  • NTCT $3.29
  • Revenue Next Year
  • ARQT $37.98
  • NTCT $2.93
  • P/E Ratio
  • ARQT N/A
  • NTCT N/A
  • Revenue Growth
  • ARQT 100.03
  • NTCT N/A
  • 52 Week Low
  • ARQT $7.86
  • NTCT $17.73
  • 52 Week High
  • ARQT $17.75
  • NTCT $27.89
  • Technical
  • Relative Strength Index (RSI)
  • ARQT 51.91
  • NTCT 64.03
  • Support Level
  • ARQT $13.47
  • NTCT $24.25
  • Resistance Level
  • ARQT $14.69
  • NTCT $25.23
  • Average True Range (ATR)
  • ARQT 0.63
  • NTCT 0.54
  • MACD
  • ARQT 0.05
  • NTCT 0.05
  • Stochastic Oscillator
  • ARQT 68.53
  • NTCT 81.22

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About NTCT NetScout Systems Inc.

NetScout Systems Inc is a provider of service assurance and cybersecurity solutions to enterprise and government networks. It bases its solutions on proprietary adaptive service intelligence technology, which helps customers monitor and identify performance issues and provides insight into network-based security threats. These solutions also deliver real-time and historical information, which provides insight to restore service and understand the quality of user experience. The company derives revenue from the sale of network management tools and security solutions. Its geographical regions include USA, which derives maximum revenue, Europe, Asia, and Rest of the World.

Share on Social Networks: